IO Biotech (IOBT) Expected to Announce Quarterly Earnings on Tuesday

IO Biotech (NASDAQ:IOBT) is expected to announce its Q1 2025 earnings results before the market opens on Tuesday, May 13th. Analysts expect IO Biotech to post earnings of ($0.45) per share for the quarter.

IO Biotech Price Performance

IO Biotech stock opened at $1.00 on Monday. The firm has a fifty day moving average price of $0.95 and a two-hundred day moving average price of $0.94. The firm has a market cap of $65.88 million, a price-to-earnings ratio of -0.73 and a beta of 0.09. IO Biotech has a fifty-two week low of $0.66 and a fifty-two week high of $1.73.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. HC Wainwright reissued a “buy” rating and issued a $12.00 target price on shares of IO Biotech in a research note on Tuesday, April 1st. Piper Sandler upgraded shares of IO Biotech to a “strong-buy” rating in a research report on Wednesday, March 12th.

IO Biotech Company Profile

IO Biotech, Inc, a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer.